Literature DB >> 15200066

Analysis of subarachnoid hemorrhage according to the Japanese Standard Stroke Registry Study--incidence, outcome, and comparison with the International Subarachnoid Aneurysm Trial.

Fusao Ikawa1, Naohiko Ohbayashi, Yasutaka Imada, Toshinori Matsushige, Yosuke Kajihara, Tetsuji Inagawa, Shotai Kobayashi.   

Abstract

The data for subarachnoid hemorrhage (SAH) from the Japanese Standard Stroke Registry Study (JSSRS) were analyzed to evaluate the incidence of SAH according to age, neurological grading and outcome, and outcome of surgical clipping, for comparison with the International Subarachnoid Aneurysm Trial (ISAT). From the ISSRS data, the peak incidence of SAH was the sixth decade in males and the eighth decade in females. The overall mortality was 22%, and good outcome, better than 2 on the modified Rankin Scale (mRS), at discharge was achieved in 58% of cases. Radical treatment was performed in 62.6% of all SAH cases, 58.7% with surgical clipping and 3.2% with endovascular coiling. Poor outcome, worse than 3 on the mRS, occurred in 26.6% of patients under 60 years, 47.3% between 60-69 years, 54.2% between 70-79 years, and 72.9% 80 years or over. From the ISAT data, 88% of patients were in grades 1-2 of the World Federation of Neurological Surgeons (WFNS) grading system in both surgical clipping and endovascular coiling groups, 94% in grades 1-3, and 98% in grades 1-4. Poor outcome, worse than 3 on the mRS, at 2 months occurred in 25.4% and 36.4% of patients with endovascular coiling and surgical clipping, respectively. Limiting the patients in the JSSRS to WFNS grades 1-2 showed poor outcome, worse than 3 on the mRS, occurred in 12.8%, and in grades 1-3 and 1-4 occurred in only 16.3% and 23.0%, respectively.

Entities:  

Mesh:

Year:  2004        PMID: 15200066     DOI: 10.2176/nmc.44.275

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  6 in total

1.  Factors associated with clinical and radiological status on admission in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Daniel W Zumofen; Michel Roethlisberger; Rita Achermann; Schatlo Bawarjan; Martin N Stienen; Christian Fung; Donato D'Alonzo; Nicolai Maldaner; Andrea Ferrari; Marco V Corniola; Daniel Schoeni; Johannes Goldberg; Daniele Valsecchi; Thomas Robert; Rodolfo Maduri; Martin Seule; Jan-Karl Burkhardt; Serge Marbacher; Philippe Bijlenga; Kristine A Blackham; Heiner C Bucher; Luigi Mariani; Raphael Guzman
Journal:  Neurosurg Rev       Date:  2018-02-10       Impact factor: 3.042

Review 2.  Epidemiology of traumatic brain injury and subarachnoid hemorrhage.

Authors:  José León-Carrión; María del Rosario Domínguez-Morales; Juan Manuel Barroso y Martín; Francisco Murillo-Cabezas
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

3.  Effect of actual age on outcome at discharge in patients by surgical clipping and endovascular coiling for ruptured cerebral aneurysm in Japan.

Authors:  Fusao Ikawa; Masaru Abiko; Daizo Ishii; Jyumpei Ohshita; Takahito Okazaki; Shigeyuki Sakamoto; Shotai Kobayashi; Kaoru Kurisu
Journal:  Neurosurg Rev       Date:  2018-01-15       Impact factor: 3.042

4.  Endovascular treatment of aneurysmal subarachnoid hemorrhage in Japanese Registry of Neuroendovascular Therapy (JR-NET) 1 and 2.

Authors:  Hirotoshi Imamura; Nobuyuki Sakai; Chiaki Sakai; Toshiyuki Fujinaka; Akira Ishii
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-12-27       Impact factor: 1.742

5.  Subarachnoid hemorrhage due to nonbranching aneurysm of the middle cerebral artery in a young adult with a history of Kawasaki disease.

Authors:  Atsushi Ishida; Seigo Matsuo; Shunji Kawamura; Toshio Nishikawa
Journal:  Surg Neurol Int       Date:  2014-01-17

6.  Does Age Affects the Surgical Outcome in Patients with Unruptured Cerebral Aneurysms? A 2-Year Retrospective Study from a Single Center in Japan.

Authors:  Shyam Duvuru; Treepob Sae-Ngow; Yoko Kato; Tsukasa Kawase; Yasuhiro Yamada; Riki Tanaka
Journal:  Asian J Neurosurg       Date:  2018 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.